Department of Orthopaedic Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan.
Int Orthop. 2022 Jul;46(7):1563-1571. doi: 10.1007/s00264-022-05375-4. Epub 2022 Mar 15.
We compared the magnetic resonance imaging (MRI)-confirmed cyst formation rate after meniscal tear repair using a new all-inside suture device (N group) versus the older all-inside suture device (O group).
Between October 2008 and July 2017, 94 consecutive menisci of 89 patients were diagnosed with meniscal tears and underwent arthroscopic meniscal repair using the all-inside suture device. Five of these patients were lost to follow-up within 12 months and were excluded from the study. The remaining 89 menisci were followed up for at least 12 months and were included in this retrospective cohort study. Older all-inside suture devices (FasT-Fix, Ultra FasT-Fix) were used until December 2012, while the new all-inside suture device (FasT-Fix 360) was used from January 2013 onwards. Meniscal cysts were detected on T2-weighted fat-suppressed MRI at 12 months postoperatively. Multiple logistic regression analysis was used to identify demographic and clinical factors associated with the use of the new all-inside suture device and cyst formation.
In total, 36 and 53 menisci were included in the N and O groups, respectively. The incidence of meniscal cysts was significantly greater in the O group (14 out of 53, 26.4%) than in the N group (two out of 36, 5.56%) (P = 0.012). Two patients in the O group had symptomatic cysts that required removal. Multivariate logistic analyses showed that the cyst formation risk significantly decreased after using the new all-inside suture device than the older all-inside suture devices (odds ratio = 0.139; P = 0.04).
The MRI-confirmed cyst formation rate after meniscal tear repair was significantly lower using the new than the older all-inside suture devices, indicating that the use of a low-profile device may decrease the cyst formation rate.
我们比较了使用新型全内缝合装置(N 组)与旧型全内缝合装置(O 组)修复半月板撕裂后磁共振成像(MRI)确认的囊肿形成率。
2008 年 10 月至 2017 年 7 月,对 89 例患者的 94 个半月板撕裂行关节镜半月板修复术,均使用全内缝合装置。这些患者中有 5 例在 12 个月内失访,被排除在研究之外。其余 89 个半月板至少随访 12 个月,被纳入本回顾性队列研究。旧型全内缝合装置(FasT-Fix、Ultra FasT-Fix)一直使用至 2012 年 12 月,而新型全内缝合装置(FasT-Fix 360)自 2013 年 1 月开始使用。术后 12 个月时,采用 T2 加权脂肪抑制 MRI 检测半月板囊肿。采用多变量逻辑回归分析确定与使用新型全内缝合装置和囊肿形成相关的人口统计学和临床因素。
共纳入 N 组和 O 组各 36 个和 53 个半月板。O 组(14/53,26.4%)的半月板囊肿发生率明显高于 N 组(2/36,5.56%)(P=0.012)。O 组中有 2 例患者出现有症状的囊肿,需要切除。多变量逻辑分析显示,使用新型全内缝合装置后,囊肿形成风险显著降低(比值比=0.139;P=0.04)。
与旧型全内缝合装置相比,新型全内缝合装置修复半月板撕裂后 MRI 确认的囊肿形成率显著降低,表明使用低轮廓装置可能会降低囊肿形成率。